biote (BTMD) to Release Quarterly Earnings on Thursday

biote (NASDAQ:BTMD) is scheduled to be announcing its earnings results after the market closes on Thursday, August 8th. Analysts expect the company to announce earnings of $0.09 per share for the quarter. Investors interested in listening to the company’s conference call can do so using this link.

biote (NASDAQ:BTMD) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.23 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.05 by $0.18. The business had revenue of $46.80 million during the quarter, compared to the consensus estimate of $47.09 million. biote had a negative return on equity of 36.67% and a net margin of 4.30%. On average, analysts expect biote to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

biote Stock Performance

NASDAQ:BTMD opened at $7.01 on Wednesday. The company has a market cap of $434.87 million, a PE ratio of 63.73 and a beta of 0.98. biote has a 52-week low of $3.65 and a 52-week high of $8.44. The stock has a 50-day simple moving average of $7.30 and a 200 day simple moving average of $6.11.

Insider Buying and Selling

In related news, CFO Robert Charles Peterson sold 11,376 shares of the stock in a transaction dated Tuesday, July 9th. The stock was sold at an average price of $7.57, for a total transaction of $86,116.32. Following the completion of the transaction, the chief financial officer now directly owns 32,874 shares in the company, valued at $248,856.18. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. 13.90% of the stock is owned by corporate insiders.

biote Company Profile

biote Corp. operates in practice-building business within the hormone optimization space. It trains physicians and nurse practitioners in hormone optimization using bioidentical hormone replacement pellet therapy in men and women experiencing hormonal imbalance. The company offers Biote Method, a comprehensive end-to-end practice building platform that provides Biote-certified practitioners with the components developed for practitioners in the hormone optimization space comprising Biote Method education, training, and certification services; practice management software that allows Biote-certified practitioners to order, track, and manage hormone optimization product inventory and other administrative requirements; inventory management software to monitor pellet inventory; and information regarding available hormone replacement therapy products, as well as digital and point-of-care marketing support.